Wyndham Franklin Plaza Hotel, Philadelphia, PA
July 14-15, 2004
In 2004, attendees to this annual global summit meeting will benefit from greatly expanded coverage into several topics of fast-growing importance: offshore outsourcing is becoming a topic of even greater interest and has such those countries with the largest efforts have each been scheduled as panel exercises.Additionally, we have continued to layer on greater chemistry coverage as this is an area where much activity is developing and hence interest lies. This year's meeting offers considerably greater emphasis on early discovery outsourcing, as well, as process research and development, intermediates, API, and manufacturing. Also added are the series' first forays into discovery biology outsourcing, such as ADME and toxicology studies, assay development, high-throughput screening, and lead optimization. Please bear in mind that this series has become an important meeting of buyers and sellers and offers both a large exposition of fine service providers as well as high-level pharmaceutical buyers from around the world - you need not necessarily attend Informex or CPHI to reach the vendors or buyers you seek - their numbers increase each year. Whether you work for a pharmaceutical, biotechnology, fine chemical, custom synthesis, or other contract research organization, this is the series you will want to attend, year after year.
|
|